132 related articles for article (PubMed ID: 10683317)
41. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
42. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
43. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
[TBL] [Abstract][Full Text] [Related]
44. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
[TBL] [Abstract][Full Text] [Related]
45. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
[TBL] [Abstract][Full Text] [Related]
46. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
[TBL] [Abstract][Full Text] [Related]
47. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
48. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
49. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
Hsu CC; Lin TW; Chang WW; Wu CY; Lo WH; Wang PH; Tsai YC
Gynecol Oncol; 2005 Feb; 96(2):415-22. PubMed ID: 15661230
[TBL] [Abstract][Full Text] [Related]
50. Alteration of sialyl Lewis epitope expression in pterygium.
Creuzot-Garcher C; Guerzider V; Assem M; Bron AM; Delannoy P; Bara J
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1631-6. PubMed ID: 10393028
[TBL] [Abstract][Full Text] [Related]
51. Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cells.
Zhang B; Chen D; Wang G; Wu Y
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):283-5. PubMed ID: 14526435
[TBL] [Abstract][Full Text] [Related]
52. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.
Pérez-Garay M; Arteta B; Pagès L; de Llorens R; de Bolòs C; Vidal-Vanaclocha F; Peracaula R
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824144
[TBL] [Abstract][Full Text] [Related]
53. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
54. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
[TBL] [Abstract][Full Text] [Related]
55. Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis.
Wang PH; Li YF; Juang CM; Lee YR; Chao HT; Ng HT; Tsai YC; Yuan CC
Gynecol Oncol; 2002 Jul; 86(1):45-52. PubMed ID: 12079299
[TBL] [Abstract][Full Text] [Related]
56. Critical role of evolutionarily conserved glycosylation at Asn211 in the intracellular trafficking and activity of sialyltransferase ST3Gal-II.
Ruggiero FM; Vilcaes AA; Iglesias-Bartolomé R; Daniotti JL
Biochem J; 2015 Jul; 469(1):83-95. PubMed ID: 25916169
[TBL] [Abstract][Full Text] [Related]
57. The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach.
Harduin-Lepers A; Mollicone R; Delannoy P; Oriol R
Glycobiology; 2005 Aug; 15(8):805-17. PubMed ID: 15843597
[TBL] [Abstract][Full Text] [Related]
58. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
59. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
60. Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.
Uslupehlivan M; Şener E; İzzetoğlu S
Carbohydr Res; 2019 Dec; 486():107823. PubMed ID: 31557542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
